Provided by Tiger Trade Technology Pte. Ltd.

Belite Bio, Inc.

158.87
-2.1900-1.36%
Post-market: 156.00-2.8700-1.81%17:29 EDT
Volume:135.33K
Turnover:21.57M
Market Cap:6.40B
PE:-58.02
High:162.39
Open:162.39
Low:157.77
Close:161.06
52wk High:200.00
52wk Low:62.18
Shares:40.27M
Float Shares:19.38M
Volume Ratio:0.99
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7382
EPS(LYR):-2.3141
ROE:-22.10%
ROA:-15.65%
PB:8.24
PE(LYR):-68.65

Loading ...

Belite Bio CFO Hao-Yuan Chuang sells USD 1.1 million in shares

Reuters
·
Apr 14

Belite Bio Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 13

Belite Bio Faces Higher Compliance Burden as It Becomes a Large Accelerated Filer, Raising Costs and Operational Risk

TIPRANKS
·
Apr 01

Belite Bio FY25 net loss widens to US$ 78 million; operating loss more than doubles to US$ 84 million

Reuters
·
Apr 01

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

GlobeNewswire
·
Mar 31

Belite Bio Director Gary Clark Biddle Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Belite Bio CEO Yu-Hsin Lin files initial beneficial ownership statement

Reuters
·
Mar 19

Belite Bio Director Chen Wan-Shan Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Belite Bio Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
Mar 14

Belite Bio, Inc. ADR (BLTE) Receives a Buy from Maxim Group

TIPRANKS
·
Mar 05

Belite Bio Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 03

Belite Bio price target raised to $201 from $191 at Morgan Stanley

TIPRANKS
·
Mar 03

Belite Bio Inc : Bofa Global Research Raises Price Objective to $200.00 From $195.00

THOMSON REUTERS
·
Mar 03

U.S. RESEARCH ROUNDUP-Block, Sherwin-Williams, Union Pacific

Reuters
·
Mar 03

Belite Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 03

Stock Track | Belite Bio Plummets 5.94% Intraday After Q4 Earnings Miss and Widening Losses

Stock Track
·
Mar 02

Belite Bio to Join Fireside Chat at Leerink Global Healthcare Conference

Reuters
·
Mar 02

Belite Bio Q4 EPS $(0.70) Misses $(0.54) Estimate

Benzinga Earnings
·
Mar 02

Belite Bio sees FY25 adjusted EPS ($1.15) vs. ($89c) last year

TIPRANKS
·
Mar 02

Belite Bio reports rise in Q4 preliminary net loss

Reuters
·
Mar 02